BioCentury
ARTICLE | Clinical News

Rituxan rituximab: Preliminary Phase IIb data

June 13, 2005 7:00 AM UTC

In the double-blind, international Phase IIb DANCER trial in 465 patients, varying doses of Rituxan plus a stable dose of methotrexate (MTX) in 9 different arms led to significant improvement in RA sy...